Top

BY Jill Russell, Ph.D.

Researchers at The University of Texas MD Anderson Cancer Center have shown how pretreatment clonal complexity in pancreatic tumor cells leads to chemotherapy resistance, findings that could lead to better-personalized and effective combination therapies.

Tumorigenesis is an evolutionary process. “A tumor is an ecosystem composed of different cell populations, and the fittest survive,” says Alessandro Carugo, Ph.D., research scientist...

Pancreatic cancer cells

BY Ron Gilmore

Researchers at MD Anderson Cancer Center have defined a new oncogene for B-cell lymphomas. The cancer-causing gene, known as heterogeneous...

BY Clayton R. Boldt, Ph.D.

The Therapeutics Discovery division at MD Anderson Cancer Center has advanced a new small-molecule inhibitor of cancer metabolism to Phase...

BY Jill Russell, Ph.D.

Immunology research to investigate the mechanisms of a new aerosol treatment, which induces an innate immune response to protect against pathogens that cause pneumonia, asthma, and other lung diseases, has earned major funding from the National Heart, Lung, and Blood Institute.

“This research will help protect patients who are most vulnerable to pneumonia, especially patients with cancer,” said Scott Evans, M.D., the principal...

Pneumonia in the lungs